S&P 500   2,731.93 (+2.56%)
DOW   23,356.02 (+2.98%)
QQQ   200.51 (+2.05%)
AAPL   266.35 (+1.48%)
FB   170.55 (+3.01%)
MSFT   166.89 (+0.98%)
GOOGL   1,198.20 (+1.29%)
AMZN   2,024.57 (+1.35%)
CGC   14.83 (+3.35%)
NVDA   268.49 (+0.03%)
BABA   199.72 (+1.66%)
MU   47.59 (+2.63%)
GE   7.35 (+1.52%)
TSLA   555.50 (+7.61%)
AMD   48.79 (+2.67%)
T   30.62 (+4.01%)
ACB   0.81 (+1.24%)
NFLX   378.18 (-0.47%)
BAC   22.69 (+6.03%)
GILD   75.49 (-2.89%)
DIS   104.19 (+4.63%)
PRI   92.24 (+5.91%)
S&P 500   2,731.93 (+2.56%)
DOW   23,356.02 (+2.98%)
QQQ   200.51 (+2.05%)
AAPL   266.35 (+1.48%)
FB   170.55 (+3.01%)
MSFT   166.89 (+0.98%)
GOOGL   1,198.20 (+1.29%)
AMZN   2,024.57 (+1.35%)
CGC   14.83 (+3.35%)
NVDA   268.49 (+0.03%)
BABA   199.72 (+1.66%)
MU   47.59 (+2.63%)
GE   7.35 (+1.52%)
TSLA   555.50 (+7.61%)
AMD   48.79 (+2.67%)
T   30.62 (+4.01%)
ACB   0.81 (+1.24%)
NFLX   378.18 (-0.47%)
BAC   22.69 (+6.03%)
GILD   75.49 (-2.89%)
DIS   104.19 (+4.63%)
PRI   92.24 (+5.91%)
S&P 500   2,731.93 (+2.56%)
DOW   23,356.02 (+2.98%)
QQQ   200.51 (+2.05%)
AAPL   266.35 (+1.48%)
FB   170.55 (+3.01%)
MSFT   166.89 (+0.98%)
GOOGL   1,198.20 (+1.29%)
AMZN   2,024.57 (+1.35%)
CGC   14.83 (+3.35%)
NVDA   268.49 (+0.03%)
BABA   199.72 (+1.66%)
MU   47.59 (+2.63%)
GE   7.35 (+1.52%)
TSLA   555.50 (+7.61%)
AMD   48.79 (+2.67%)
T   30.62 (+4.01%)
ACB   0.81 (+1.24%)
NFLX   378.18 (-0.47%)
BAC   22.69 (+6.03%)
GILD   75.49 (-2.89%)
DIS   104.19 (+4.63%)
PRI   92.24 (+5.91%)
S&P 500   2,731.93 (+2.56%)
DOW   23,356.02 (+2.98%)
QQQ   200.51 (+2.05%)
AAPL   266.35 (+1.48%)
FB   170.55 (+3.01%)
MSFT   166.89 (+0.98%)
GOOGL   1,198.20 (+1.29%)
AMZN   2,024.57 (+1.35%)
CGC   14.83 (+3.35%)
NVDA   268.49 (+0.03%)
BABA   199.72 (+1.66%)
MU   47.59 (+2.63%)
GE   7.35 (+1.52%)
TSLA   555.50 (+7.61%)
AMD   48.79 (+2.67%)
T   30.62 (+4.01%)
ACB   0.81 (+1.24%)
NFLX   378.18 (-0.47%)
BAC   22.69 (+6.03%)
GILD   75.49 (-2.89%)
DIS   104.19 (+4.63%)
PRI   92.24 (+5.91%)
Log in

ASX:IBXImagion Biosys Stock Price, Forecast & News

Add
Compare
Today's Range N/A
50-Day Range
A$0.02
MA: A$0.04
A$0.05
52-Week Range N/A
Volume3.71 million shs
Average VolumeN/A
Market Capitalization$15.81 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Imagion Biosystems Limited provides tools to detect and eliminate cancer. It has activities in nanotechnology; biotechnology; cancer diagnostics; and superparamagnetic relaxometry. The company was founded in 1996 and is based in San Diego, California.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.8Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.56 out of 5 stars


Industry, Sector and Symbol

Industry Diagnostics & Research
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone855-564-5264

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$2.49 million
Book ValueA$0.01 per share

Profitability

Miscellaneous

EmployeesN/A
Market Cap$15.81 million
Next Earnings DateN/A
OptionableNot Optionable

Receive IBX News and Ratings via Email

Sign-up to receive the latest news and ratings for IBX and its competitors with MarketBeat's FREE daily newsletter.


Imagion Biosys (ASX:IBX) Frequently Asked Questions

Has Imagion Biosys been receiving favorable news coverage?

News stories about IBX stock have trended very negative on Tuesday, according to InfoTrie. The research group identifies negative and positive news coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Imagion Biosys earned a media sentiment score of -3.3 on InfoTrie's scale. They also assigned news articles about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the company's share price in the immediate future. View the latest news aboutImagion Biosys.

Who are some of Imagion Biosys' key competitors?

What other stocks do shareholders of Imagion Biosys own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Imagion Biosys investors own include Pyxus International (PYX), Alibaba Group (BABA), Arcadia Biosciences (RKDA) and Amani Gold (ANL).

Who are Imagion Biosys' key executives?

Imagion Biosys' management team includes the following people:
  • Mr. Robert Romeo Proulx, Exec. Chairman, Pres & CEO (Age 61)
  • Mr. Brian D. Conn, Chief Financial Officer
  • Ms. Jovanka Naumoska, Company Sec. & Non Exec. Director
  • Dr. Marie Zhang, Vice-Pres of Research & Pre- Clinical Dev

What is Imagion Biosys' stock symbol?

Imagion Biosys trades on the ASX under the ticker symbol "IBX."

How big of a company is Imagion Biosys?

Imagion Biosys has a market capitalization of $0.00 and generates $2.49 million in revenue each year.  View additional information about Imagion Biosys.

What is Imagion Biosys' official website?

The official website for Imagion Biosys is http://www.imagionbiosystems.com/.

How can I contact Imagion Biosys?

The company can be reached via phone at 855-564-5264.

This page was last updated on 4/7/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel